Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
We are pleased to introduce Chris Smyth, Group CEO of Comac Medical, through this three-part in-depth interview series....
[Sofia, Bulgaria] – Recycling at our HQ matters. Every item disposed of correctly helps us reduce waste and use...
In today’s fast-evolving biotech landscape, choosing the right biotech CRO (Contract Research Organization) can be the single most...